EI
LOXO

EAM Investors’s Loxo Oncology, Inc LOXO Stock Holding History

EAM Investors’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-13,593
Closed -$2.32M – 367
2018
Q3 		$2.32M Sell
13,593
-3,310
-20% -$556K 0.35% 139
2018
Q2 		$2.93M Sell
16,903
-7,962
-32% -$1.2M 0.46% 98
2018
Q1 		$2.87M Buy
+24,865
New +$2.64M 0.48% 101
2017
Q4 		– Sell
-46,993
Closed -$4.33M – 384
2017
Q3 		$4.33M Sell
46,993
-27,147
-37% -$2.11M 0.58% 42
2017
Q2 		$5.95M Sell
74,140
-29,009
-28% -$1.61M 0.98% 1
2017
Q1 		$4.34M Sell
103,149
-8,119
-7% -$334K 0.68% 15
2016
Q4 		$3.57M Buy
111,268
+26,207
+31% +$672K 0.48% 47
2016
Q3 		$2.23M Sell
85,061
-114,669
-57% -$3M 0.3% 175
2016
Q2 		$4.63M Sell
199,730
-15,129
-7% -$377K 0.7% 5
2016
Q1 		$5.87M Buy
214,859
+105,004
+96% +$2.2M 0.92% 5
2015
Q4 		$3.13M Sell
109,855
-12,697
-10% -$341K 0.41% 101
2015
Q3 		$2.14M Buy
122,552
+45,745
+60% +$895K 0.34% 134
2015
Q2 		$1.39M Buy
+76,807
New +$1.05M 0.16% 244

Other funds holding LOXO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM Investors's LOXO Position: Q4 2018 in Review

EAM Investors sold out of Loxo Oncology, Inc (LOXO) in Q4 2018, closing a stake of 13,593 shares — an estimated $2.32M sold.

EAM Investors first reported a position in LOXO in Q2 2015 and held it in 13 quarters. The position peaked at $5.95M in Q2 2017. 232 funds tracked by Wall St. Rank hold LOXO as of Q4 2018.

  • EAM Investors reported no remaining Loxo Oncology, Inc position as of Q4 2018 after selling out during the quarter.
  • EAM Investors sold 13,593 Loxo Oncology, Inc shares in Q4 2018, an estimated $2.32M.
  • EAM Investors first reported a position in Loxo Oncology, Inc in Q2 2015 and held it in 13 quarters.
  • EAM Investors's Loxo Oncology, Inc position peaked at $5.95M in Q2 2017.
  • 232 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2018.

Based on EAM Investors's 13F filing for Q4 2018, filed 13 Feb 2019.